Metro Boston Biotech Beat | Q3 2017
Net absorption was essentially flat in the Greater Boston lab market during the third quarter; keeping vacancies elevated at 3.6%. A handful of factors have weighed on demand-side fundamentals in recent quarters. The typical boom-and-bust among pharmaceutical companies and recent M&A activity have led to the consolidation of space in Cambridge. That said, expansions and relocations dominated third-quarter leasing here, which bodes well for near-term market fundamentals. Read more in our Q3 Biotech Beat.